APOA1 and COVID-19: This is characterized by a decrease in apolipoprotein A1 and HDL cholesterol, which was evident in our COVID-19 cohort where we identified a decrease in total (TPA1 and TPCH, respectively) and HDL groups (HDA1 and H4A1, and HDCH and H4CH, respectively).